Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -3.68% | +8.68% | -31.59% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
9,359 PTS | +0.96% | +1.91% | - | ||
369.5 PTS | +0.05% | +2.31% | - | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.59% | 645M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N.V. Announces Results of the Second Interim Analysis of its International Pivotal Phase 2b/3 Study in Approximatively 40,000 Subjects